Asthma - Pipeline Review, H1 2018
SKU ID :GMD-11538231 | Published Date: 30-Apr-2018 | No. of pages: 592Description
TOC
Table of Contents
Table of Contents 2
Introduction 8
Asthma - Overview 9
Asthma - Therapeutics Development 10
Asthma - Therapeutics Assessment 37
Asthma - Companies Involved in Therapeutics Development 55
Asthma - Drug Profiles 108
Asthma - Dormant Projects 524
Asthma - Discontinued Products 549
Asthma - Product Development Milestones 555
Appendix 566
Tables & Figures
List of Tables
Table 1: Number of Products under Development for Asthma, H1 2018
Table 2: Number of Products under Development by Companies, H1 2018
Table 3: Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Table 4: Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Table 5: Number of Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Table 6: Number of Products under Development by Companies, H1 2018 (Contd..4), H1 2018
Table 7: Number of Products under Development by Companies, H1 2018 (Contd..5), H1 2018
Table 8: Number of Products under Development by Companies, H1 2018 (Contd..6), H1 2018
Table 9: Number of Products under Development by Companies, H1 2018 (Contd..7), H1 2018
Table 10: Number of Products under Development by Universities/Institutes, H1 2018
Table 11: Products under Development by Companies, H1 2018
Table 12: Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Table 13: Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Table 14: Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Table 15: Products under Development by Companies, H1 2018 (Contd..4), H1 2018
Table 16: Products under Development by Companies, H1 2018 (Contd..5), H1 2018
Table 17: Products under Development by Companies, H1 2018 (Contd..6), H1 2018
Table 18: Products under Development by Companies, H1 2018 (Contd..7), H1 2018
Table 19: Products under Development by Companies, H1 2018 (Contd..8), H1 2018
Table 20: Products under Development by Companies, H1 2018 (Contd..9), H1 2018
Table 21: Products under Development by Companies, H1 2018 (Contd..10), H1 2018
Table 22: Products under Development by Companies, H1 2018 (Contd..11), H1 2018
Table 23: Products under Development by Universities/Institutes, H1 2018
Table 24: Products under Development by Universities/Institutes, H1 2018 (Contd..1), H1 2018
Table 25: Number of Products by Stage and Target, H1 2018
Table 26: Number of Products by Stage and Target, H1 2018 (Contd..1), H1 2018
Table 27: Number of Products by Stage and Target, H1 2018 (Contd..2), H1 2018
Table 28: Number of Products by Stage and Target, H1 2018 (Contd..3), H1 2018
Table 29: Number of Products by Stage and Target, H1 2018 (Contd..4), H1 2018
Table 30: Number of Products by Stage and Target, H1 2018 (Contd..5), H1 2018
Table 31: Number of Products by Stage and Mechanism of Action, H1 2018
Table 32: Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..1), H1 2018
Table 33: Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..2), H1 2018
Table 34: Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..3), H1 2018
Table 35: Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..4), H1 2018
Table 36: Number of Products by Stage and Mechanism of Action, H1 2018 (Contd..5), H1 2018
Table 37: Number of Products by Stage and Route of Administration, H1 2018
Table 38: Number of Products by Stage and Molecule Type, H1 2018
Table 39: Asthma - Pipeline by 4D Pharma PLC, H1 2018
Table 40: Asthma - Pipeline by AB Science SA, H1 2018
Table 41: Asthma - Pipeline by AbbVie Inc, H1 2018
Table 42: Asthma - Pipeline by Abeome Corp, H1 2018
Table 43: Asthma - Pipeline by Accolade Pharmaceuticals LLC, H1 2018
Table 44: Asthma - Pipeline by Adamis Pharmaceuticals Corp, H1 2018
Table 45: Asthma - Pipeline by ALK-Abello AS, H1 2018
Table 46: Asthma - Pipeline by Allergan Plc, H1 2018
Table 47: Asthma - Pipeline by Allergopharma GmbH & Co KG, H1 2018
Table 48: Asthma - Pipeline by Almirall SA, H1 2018
Table 49: Asthma - Pipeline by Amgen Inc, H1 2018
Table 50: Asthma - Pipeline by Amphastar Pharmaceuticals Inc, H1 2018
Table 51: Asthma - Pipeline by AnaptysBio Inc, H1 2018
Table 52: Asthma - Pipeline by AnGes Inc, H1 2018
Table 53: Asthma - Pipeline by Antisense Therapeutics Ltd, H1 2018
Table 54: Asthma - Pipeline by Apollo Endosurgery Inc, H1 2018
Table 55: Asthma - Pipeline by ARA Healthcare Pvt Ltd, H1 2018
Table 56: Asthma - Pipeline by ASIT Biotech SA, H1 2018
Table 57: Asthma - Pipeline by Aslan Pharmaceuticals Pte Ltd, H1 2018
Table 58: Asthma - Pipeline by Astellas Pharma Inc, H1 2018
Table 59: Asthma - Pipeline by AstraZeneca Plc, H1 2018
Table 60: Asthma - Pipeline by Aurigene Discovery Technologies Ltd, H1 2018
Table 61: Asthma - Pipeline by Biotec Pharmacon ASA, H1 2018
Table 62: Asthma - Pipeline by Boehringer Ingelheim GmbH, H1 2018
Table 63: Asthma - Pipeline by Cellular Biomedicine Group Inc, H1 2018
Table 64: Asthma - Pipeline by Celon Pharma SA, H1 2018
Table 65: Asthma - Pipeline by Chiesi Farmaceutici SpA, H1 2018
Table 66: Asthma - Pipeline by Circassia Pharmaceuticals Plc, H1 2018
Table 67: Asthma - Pipeline by Cognosci Inc, H1 2018
Table 68: Asthma - Pipeline by Crossject SA, H1 2018
Table 69: Asthma - Pipeline by CrystalGenomics Inc, H1 2018
Table 70: Asthma - Pipeline by CSL Ltd, H1 2018
List of Figures
Figure 1: Number of Products under Development for Asthma, H1 2018
Figure 2: Number of Products under Development by Companies, H1 2018
Figure 3: Number of Products under Development by Universities/Institutes, H1 2018
Figure 4: Number of Products by Top 10 Targets, H1 2018
Figure 5: Number of Products by Stage and Top 10 Targets, H1 2018
Figure 6: Number of Products by Top 10 Mechanism of Actions, H1 2018
Figure 7: Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Figure 8: Number of Products by Top 10 Routes of Administration, H1 2018
Figure 9: Number of Products by Stage and Top 10 Routes of Administration, H1 2018
Figure 10: Number of Products by Top 10 Molecule Types, H1 2018
Figure 11: Number of Products by Stage and Top 10 Molecule Types, H1 2018
Companies
4D Pharma PLC
AB Science SA
AbbVie Inc
Abeome Corp
Accolade Pharmaceuticals LLC
Adamis Pharmaceuticals Corp
ALK-Abello AS
Allergan Plc
Allergopharma GmbH & Co KG
Almirall SA
Amgen Inc
Amphastar Pharmaceuticals Inc
AnaptysBio Inc
AnGes Inc
Antisense Therapeutics Ltd
Apollo Endosurgery Inc
ARA Healthcare Pvt Ltd
ASIT Biotech SA
Aslan Pharmaceuticals Pte Ltd
Astellas Pharma Inc
AstraZeneca Plc
Aurigene Discovery Technologies Ltd
Biotec Pharmacon ASA
Boehringer Ingelheim GmbH
Cellular Biomedicine Group Inc
Celon Pharma SA
Chiesi Farmaceutici SpA
Circassia Pharmaceuticals Plc
Cognosci Inc
Crossject SA
CrystalGenomics Inc
CSL Ltd
Cumberland Pharmaceuticals Inc
Cynata Therapeutics Ltd
Cytokinetics Inc
Daiichi Sankyo Co Ltd
Denceptor Therapeutics Ltd
Energenesis Biomedical Co Ltd
Enterprise Therapeutics Ltd
F. Hoffmann-La Roche Ltd
Fountain Biopharma Inc
Genentech Inc
GlaxoSmithKline Plc
Glenmark Pharmaceuticals Ltd
Griffin Discoveries BV
Han Wha Pharma Co Ltd
Hydra Biosciences Inc
iCeutica Inc
iCo Therapeutics Inc.
Icure Pharmaceutical Inc
Idorsia Ltd
InKemia IUCT Group SA
Inspyr Therapeutics Inc
Intech Biopharm Ltd
Invion Ltd
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Kissei Pharmaceutical Co Ltd
Knopp Biosciences LLC
Kyowa Hakko Kirin Co Ltd
Laboratorios LETI SL
Lead Discovery Center GmbH
LG Chem Ltd
Longevity Biotech Inc
Medicenna Therapeutics Corp
MedImmune LLC
Merck & Co Inc
Mitsubishi Tanabe Pharma Corp
Mycenax Biotech Inc
NAL Pharmaceuticals Ltd
NeoPharm Co Ltd
Novartis AG
Omeros Corp
Ono Pharmaceutical Co Ltd
OPKO Health Inc
Orbis Biosciences Inc
Orchid Pharma Ltd
Orion Corporation
Oxagen Ltd
Paradigm Biopharmaceuticals Ltd
Pfizer Inc
Pharmaxis Ltd
Pieris Pharmaceuticals Inc
Polyphor Ltd
Progenra Inc
Promedior Inc
Prommune Inc
Pulmagen Therapeutics LLP
Pulmatrix Inc
Pulmokine Inc
Pulmotect Inc
Qu Biologics Inc
Qurient Co Ltd
Re-Pharm Ltd
Regeneron Pharmaceuticals Inc
Reliance Life Sciences Pvt Ltd
Respiratorius AB
ReveraGen BioPharma Inc
Saje Pharma LLC
SolAeroMed Inc
Sterna biologicals GmbH & Co KG
Sumitomo Chemical Co Ltd
Sumitomo Dainippon Pharma Co Ltd
Sun Pharmaceutical Industries Ltd
Swecure AB
Synermore Biologics Co Ltd
TaiwanJ Pharmaceuticals Co Ltd
Teva Pharmaceutical Industries Ltd
The Geneva Biotech Center SA
Therabron Therapeutics Inc
Theravance Biopharma Inc
Tolerys SA
United BioPharma Inc
Vectura Group Plc
Verona Pharma Plc
WhanIn Pharmaceutical Co Ltd
Xencor Inc
Zai Lab Ltd
- PRICE
-
$2500$7500